Tag: GLTx
11
Mar
GLTx EndoC-βH5™
Revolutionize Your Glucolipotoxicity-Mediated T2D Research Open new avenue using a unique clinically relevant cell model. GLTx EndoC-βH5™ is a new human pancreatic beta cell line that has been specifically designed to recapitulate pathological glucolipotoxicity-induced dysfunction as observed in Type 2 Diabetes patients. GLTx EndoC-βH5™ cell line offers you:
Latest News
Human Cell Design provides human cells and services to accelerate and secure innovative, safe and clinically relevant scientific progress and pharmaceutical products for human health.
Beta Cells
Contact
+33 9 72 10 14 81
1 place Pierre Potier (Canceropole), Entrée B, 31106 Toulouse, France